JP2022541125A5 - - Google Patents

Info

Publication number
JP2022541125A5
JP2022541125A5 JP2021577528A JP2021577528A JP2022541125A5 JP 2022541125 A5 JP2022541125 A5 JP 2022541125A5 JP 2021577528 A JP2021577528 A JP 2021577528A JP 2021577528 A JP2021577528 A JP 2021577528A JP 2022541125 A5 JP2022541125 A5 JP 2022541125A5
Authority
JP
Japan
Prior art keywords
treatment
pharmaceutical composition
subject
classifier
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541125A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039991 external-priority patent/WO2020264426A1/en
Publication of JP2022541125A publication Critical patent/JP2022541125A/ja
Publication of JP2022541125A5 publication Critical patent/JP2022541125A5/ja
Pending legal-status Critical Current

Links

JP2021577528A 2019-06-27 2020-06-26 患者を層別化するための分類子の開発 Pending JP2022541125A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962867853P 2019-06-27 2019-06-27
US62/867,853 2019-06-27
US201962882402P 2019-08-02 2019-08-02
US62/882,402 2019-08-02
US202062965486P 2020-01-24 2020-01-24
US62/965,486 2020-01-24
PCT/US2020/039991 WO2020264426A1 (en) 2019-06-27 2020-06-26 Developing classifiers for stratifying patients

Publications (2)

Publication Number Publication Date
JP2022541125A JP2022541125A (ja) 2022-09-22
JP2022541125A5 true JP2022541125A5 (https=) 2023-05-30

Family

ID=74061318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577528A Pending JP2022541125A (ja) 2019-06-27 2020-06-26 患者を層別化するための分類子の開発

Country Status (11)

Country Link
US (5) US11195595B2 (https=)
EP (1) EP3990656B1 (https=)
JP (1) JP2022541125A (https=)
KR (1) KR20220044720A (https=)
CN (1) CN114402084A (https=)
AU (1) AU2020308906A1 (https=)
CA (1) CA3145237A1 (https=)
GB (1) GB2603294A (https=)
IL (1) IL289304A (https=)
MX (1) MX2022000128A (https=)
WO (1) WO2020264426A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7496324B2 (ja) 2018-03-16 2024-06-06 サイファー メディシン コーポレイション 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
WO2021231713A2 (en) 2020-05-14 2021-11-18 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
KR20240018404A (ko) * 2020-09-01 2024-02-13 사이퍼 메디슨 코퍼레이션 항-tnf 요법에 대한 반응을 예측하기 위한 방법 및 시스템
US11430575B2 (en) * 2020-11-13 2022-08-30 Specialty Diagnostic (SDI) Laboratories, Inc. Systems and methods for a data driven disease test result prediction
US12271832B2 (en) * 2021-02-12 2025-04-08 Tempus Ai, Inc. Artificial intelligence engine for directed hypothesis generation and ranking
AU2022240733A1 (en) * 2021-03-19 2023-09-28 Scipher Medicine Corporation Methods of classifying and treating patients
WO2022240875A1 (en) 2021-05-13 2022-11-17 Scipher Medicine Corporation Assessing responsiveness to therapy
US20220399092A1 (en) * 2021-06-10 2022-12-15 Rajant Health Inc. Ai-enabled health platform
JP2024527529A (ja) * 2021-06-22 2024-07-25 サイファー メディシン コーポレーション 治療モニタリングおよび試験設計のための方法とシステム
WO2023150731A2 (en) * 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies
CN114861764B (zh) * 2022-04-11 2024-11-22 中国科学院计算技术研究所 基于auc优化的多类别分类方法及系统
CN115206439B (zh) * 2022-05-20 2025-07-18 南开大学 跨语言平台的空间转录组数据转换方法及系统
WO2024081737A1 (en) * 2022-10-12 2024-04-18 Exagen Inc. Biomarker selection for machine learning enabled prediction of treatment response
CN116312796B (zh) * 2022-12-27 2023-11-14 江苏先声医学诊断有限公司 一种基于期望最大化算法的宏基因组丰度估计方法及系统
WO2024249568A1 (en) 2023-05-30 2024-12-05 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use
CN121889424A (zh) 2023-08-14 2026-04-17 派拉冈医疗公司 α4β7整联蛋白结合蛋白及使用方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040120952A1 (en) 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
EP1945814A2 (en) 2005-09-27 2008-07-23 Source MDX Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
CN103336129A (zh) 2005-11-01 2013-10-02 阿布维生物技术有限公司 使用生物标志物诊断强直性脊柱炎的方法和组合物
WO2007123976A2 (en) * 2006-04-18 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Antibody profiling for determination of patient responsiveness
WO2008150491A2 (en) 2007-05-31 2008-12-11 Abbott Laboratories BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS
US20100303813A1 (en) 2007-06-08 2010-12-02 Biogen Idec Ma Inc. Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
US7863021B2 (en) 2007-09-05 2011-01-04 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
EP2307563B1 (en) 2008-03-28 2014-08-06 Katholieke Universiteit Leuven KU Leuven Research & Development Mucosal gene signatures
KR20100003759A (ko) 2008-07-02 2010-01-12 양혜지 반짝이가 포함된 구두약
ES2445892T3 (es) 2008-08-25 2014-03-05 Janssen Biotech, Inc. Biomarcadores para el tratamiento anti-TNF en colitis ulcerosa y trastornos relacionados
EP2342664A1 (en) 2008-09-03 2011-07-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Computer implemented model of biological networks
CA2737485A1 (en) 2008-10-10 2010-04-15 Mount Sinai Hospital Methods for classifying samples based on network modularity
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック， インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法
WO2011047358A1 (en) 2009-10-15 2011-04-21 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
WO2011139345A2 (en) 2010-04-29 2011-11-10 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (paradigm)
US10192641B2 (en) 2010-04-29 2019-01-29 The Regents Of The University Of California Method of generating a dynamic pathway map
WO2012066536A2 (en) 2010-11-16 2012-05-24 Prediguard Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status
EP2668287B1 (en) 2011-01-25 2017-09-06 TC LAND Expression Genes and genes combinations based on gene mknk1 predictive of early response or non response of subjects suffering from rheumatoid arthritis to tnf-alpha blocking monoclonal antibody
US20130040835A1 (en) 2011-05-05 2013-02-14 Exagen Diagnostics, Inc Genes predictive of anti-TNF response in inflammatory diseases
AU2012253422B2 (en) 2011-05-10 2015-08-13 Société des Produits Nestlé S.A. Methods of disease activity profiling for personalized therapy management
CN104955845B (zh) 2012-09-27 2018-11-16 美国政府(由卫生和人类服务部的部长所代表) 间皮素抗体和引起有效的抗肿瘤活性的方法
HU230680B1 (hu) 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
EP2914739B1 (en) 2012-11-05 2017-09-13 Novigenix SA Biomarker combinations for colorectal tumors
WO2014082083A1 (en) 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
US10161936B2 (en) 2013-03-08 2018-12-25 University Of Leipzig Method and kit for cytokine analysis from a human whole blood sample
US9945870B2 (en) 2013-05-17 2018-04-17 The Board Of Trustees Of The Leland Stanford Junior University Methods for determining responsiveness to an anti-CD47 agent
WO2015006213A1 (en) 2013-07-08 2015-01-15 Northeastern University Methods for identifying complex disease subtypes
US9387246B2 (en) 2013-09-03 2016-07-12 L. Douglas Graham Treatment methods for rheumatoid arthritis
WO2015084461A2 (en) 2013-09-23 2015-06-11 Northeastern University System and methods for disease module detection
WO2015148809A1 (en) 2014-03-27 2015-10-01 Genentech, Inc. Methods for diagnosing and treating inflammatory bowel disease
WO2015153437A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
WO2015164406A1 (en) 2014-04-21 2015-10-29 University Of South Florida Salivary inflammatory biomarkers associated with glycemic control and oral health
CA2964857A1 (en) 2014-10-20 2016-04-28 Nestec S.A. Methods for prediction of anti-tnf alpha drug levels and autoantibody formation
HK1244881A1 (zh) 2014-12-02 2018-08-17 Société des Produits Nestlé S.A. 建立维多珠单坑给药方案以治疗患有易激惹肠病的患者的方法
EP3730188B1 (en) * 2015-08-21 2024-07-31 The Children's Hospital of Philadelphia Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases
ES2905536T3 (es) * 2015-10-02 2022-04-11 Momenta Pharmaceuticals Inc Procedimientos terapéuticos y de diagnóstico para enfermedades autoinmunes y/o inflamación
US10018637B2 (en) 2015-10-06 2018-07-10 Celgene International Ii Sarl Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
ES2716900T3 (es) 2015-11-06 2019-06-17 Promise Advanced Proteomics Un método para cuantificar anticuerpos anti-TNF
US20190080051A1 (en) 2015-11-11 2019-03-14 Northeastern University Methods And Systems For Profiling Personalized Biomarker Expression Perturbations
US20170145501A1 (en) 2015-11-20 2017-05-25 Lasse Folkersen Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
EP3440579A4 (en) 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
GB201521357D0 (en) 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
JP6572120B2 (ja) 2015-12-14 2019-09-04 浜松ホトニクス株式会社 光ビーム照射装置
WO2017151755A1 (en) 2016-03-02 2017-09-08 Crescendo Bioscience Biomarkers and methods for predicting response to discontinuation of inflammatory disease therapy
AU2017281039A1 (en) 2016-06-20 2019-01-24 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
US12105089B2 (en) 2017-07-17 2024-10-01 The Broad Institute, Inc. Cell atlas of the healthy and ulcerative colitis human colon
US20200165677A1 (en) 2017-07-18 2020-05-28 Thaddeus Stappenbeck Methods and uses of inflammatory bowel disease biomarkers
US10512775B2 (en) * 2017-08-30 2019-12-24 Cochlear Limited Noise reduction for implantable hearing prostheses
US20190287644A1 (en) 2018-02-15 2019-09-19 Northeastern University Correlation Method To Identify Relevant Genes For Personalized Treatment Of Complex Disease
JP7496324B2 (ja) 2018-03-16 2024-06-06 サイファー メディシン コーポレイション 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム
EA202191354A1 (ru) 2018-11-15 2021-08-11 Янссен Байотек, Инк. Способы и композиции для прогнозирования ответа на терапию воспалительного заболевания кишечника
AU2020244763A1 (en) 2019-03-22 2021-09-30 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
JP7621967B2 (ja) 2019-03-28 2025-01-27 フェーズ ゲノミクス インコーポレイテッド シーケンシングによる核型分析のためのシステムおよび方法
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
KR20240018404A (ko) 2020-09-01 2024-02-13 사이퍼 메디슨 코퍼레이션 항-tnf 요법에 대한 반응을 예측하기 위한 방법 및 시스템
AU2022240733A1 (en) 2021-03-19 2023-09-28 Scipher Medicine Corporation Methods of classifying and treating patients
WO2023150731A2 (en) 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies

Similar Documents

Publication Publication Date Title
JP2022541125A5 (https=)
GB2603294A (en) Developing classifiers for stratifying patients
JP7497084B2 (ja) がん治療の有効性を予測するためのシステムおよび方法
JP2021518432A5 (https=)
US11795496B2 (en) Epigenetic chromosome interactions
GB2622147A (en) Methods of classifying and treating patients
Chadeau-Hyam et al. Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis
JP2021518432A (ja) 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム
Quintana-Duque et al. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study
WO2022271724A1 (en) Methods and systems for therapy monitoring and trial design
JP2023538963A5 (https=)
GB2616129A (en) Methods and systems for predicting response to anti-TNF therapies
Kakurina et al. Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19
Knevel et al. Genomic influences on susceptibility and severity of rheumatoid arthritis
Song et al. Risk of venous thromboembolism in Korean patients with rheumatoid arthritis treated with Janus kinase inhibitors: A nationwide population-based study
Coto-Segura et al. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
Cappelli et al. Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis
Ao et al. Cellular senescence-associated genes in rheumatoid arthritis: Identification and functional analysis
US20250174366A1 (en) Methods and Compositions for Assessing and Treating Lupus
WO2023215618A2 (en) Methods for identifying shared biological pathways between diseases using mendelian randomization
Blundell et al. Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When?
Wang et al. Evaluation of Siltuximab and Tocilizumab Analytical Interference on Interleukin 6 Measurements
Capelusnik et al. POS0508 predictors of persistent disease in early arthritis: 12 months results
GB2547406A (en) Apparatus and methods of using of biomarkers for predicting TNF-inhibitor response
TW202449804A (zh) 用於定相腫瘤中的突變之系統及方法